|
Summit Therapeutics Inc. (SMMT) Évaluation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Summit Therapeutics Inc. (SMMT) Bundle
Évaluez les perspectives financières de Summit Therapeutics Inc. (SMMT) comme un expert! Cette calculatrice DCF (SMMT) fournit des données financières pré-remplies tout en vous permettant la liberté de modifier des hypothèses telles que la croissance des revenus, le WACC, les marges, et plus encore pour s'aligner sur vos prévisions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1 | 2.3 | .9 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 110.35 | -61.07 | -100 | 0 | -15.27 | -15.27 | -15.27 | -15.27 | -15.27 |
| EBITDA | -46.8 | -79.0 | -66.3 | 1.3 | .4 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -4317.95 | -3467.99 | -7472.75 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | 2.5 | 3.1 | 3.2 | 114.2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 232.91 | 135.71 | 356.95 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -49.3 | -82.1 | -69.4 | -113.0 | .4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -4550.85 | -3603.7 | -7829.7 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 83.6 | 90.4 | 438.9 | 234.5 | 519.1 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 12.8 | 1.8 | .4 | 1.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 1184.53 | 80.93 | 49.55 | 100 | 100 | 86.1 | 86.1 | 86.1 | 86.1 | 86.1 |
| Inventories | -14.7 | 9.0 | 379.6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | -1361.63 | 395.85 | 42809.33 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 7.7 | 5.5 | .4 | 3.4 | 5.8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 713.95 | 241.79 | 50.41 | 100 | 100 | 90.08 | 90.08 | 90.08 | 90.08 | 90.08 |
| Capital Expenditure | -.5 | -.4 | -.8 | -.2 | -.2 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -48.95 | -16.92 | -88.6 | 100 | 100 | -30.89 | -30.89 | -30.89 | -30.89 | -30.89 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -49.1 | -79.8 | -65.5 | -112.8 | .4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -37.4 | -92.1 | -437.4 | 383.1 | 3.8 | -5.8 | .0 | .0 | .0 | .0 |
| WACC, % | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -6 | |||||||||
| Net Debt | -123 | |||||||||
| Equity Value | 117 | |||||||||
| Diluted Shares Outstanding, MM | 719 | |||||||||
| Equity Value Per Share | 0.16 |
What You Will Get
- Real SMMT Financial Data: Pre-filled with Summit Therapeutics’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Summit Therapeutics’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Clinical Data: Access reliable pre-loaded historical performance metrics and future clinical projections.
- Customizable Assumptions: Modify highlighted cells for variables such as R&D expenses, market growth rates, and profit margins.
- Automated Financial Analysis: Instant updates to DCF, Net Present Value (NPV), and revenue forecasts.
- User-Friendly Dashboard: Intuitive charts and summaries to easily interpret your financial assessments.
- Designed for All Users: A straightforward, user-centric layout suitable for investors, analysts, and industry professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based SMMT DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and more.
- Instant Calculations: The model automatically recalculates Summit Therapeutics' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Summit Therapeutics Inc. (SMMT)?
- Designed for Experts: A sophisticated tool favored by analysts, investors, and healthcare consultants.
- Comprehensive Data: Summit Therapeutics' historical and projected financials preloaded for precise analysis.
- Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
- Transparent Results: Automatically computes intrinsic value, NPV, and essential metrics for informed decision-making.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Summit Therapeutics Inc. (SMMT).
- Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Summit Therapeutics Inc. (SMMT).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech firms.
- Biotech Enthusiasts: Gain insights into how companies like Summit Therapeutics Inc. (SMMT) are valued in the healthcare market.
What the Summit Therapeutics Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Summit Therapeutics Inc. (SMMT).
- Real-World Data: Summit Therapeutics’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Summit Therapeutics Inc. (SMMT).
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for informed decision-making.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.